Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

View source ↗

Summary

Recruitment is ongoing for the OPtilume BPH Catheter System intended to treat symptomatic benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Optilume BPH Catheter System

Snippet

Sponsor: Urotronic Inc. | Conditions: Benign Prostatic Hyperplasia | Status: RECRUITING